Literature DB >> 205476

Hepatic insulin responsiveness in patients with endogenous hypertriglyceridaemia.

R M Bernstein, B M Davis, J M Olefsky, G M Reaven.   

Abstract

Plasma insulin response to oral glucose, insulin resistance, and insulin suppression of hepatic glucose production were studied in 11 normal subjects and 11 hypertriglyceridaemic patients. Patients with hypertriglyceridaemia had a significantly higher insulin response to oral glucose. Insulin resistance was also significantly greater in hypertriglyceridaemic subjects as determined by measuring the steady-state plasma glucose response during a continuous infusion of epinephrine, propranolol, glucose, and exogenous insulin. Insulin suppression of hepatic glucose production was calculated from the results of two studies in which glucose turnover rate was measured by a continuous infusion of 3H-2-glucose. The first study was performed under conditions of basal insulin secretion, and the second carried out at steady state exogenous insulin levels of approximately 100 muU/ml. The results indicated that basal hepatic glucose production was the same in both groups, and was suppressed to an equal degree by physiological levels of insulin. These data demonstrate that hepatic glucose production can be suppressed to an equal degree in normal and hypertriglyceridaemic subjects at comparable circulating insulin levels, at the same time that resistance to insulin-stimulated glucose uptake is observed in the hypertriglyceridaemic individuals.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 205476     DOI: 10.1007/bf01219424

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  11 in total

1.  Reappraisal of the role of insulin in hypertriglyceridemia.

Authors:  J M Olefsky; J W Farquhar; G M Reaven
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

2.  Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man.

Authors:  J W Farquhar; A Frank; R C Gross; G M Reaven
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

3.  Increased lipid synthesis by liver slice in a superfusion system following raised glucose or insulin concentration.

Authors:  B R Tulloch; K Dyal; T R Fraser
Journal:  Diabetologia       Date:  1972-08       Impact factor: 10.122

4.  Glucose metabolism during leg exercise in man.

Authors:  J Wahren; P Felig; G Ahlborg; L Jorfeldt
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

5.  Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays.

Authors:  B Desbuquois; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

6.  Stimulation by insulin of the incorporation of U-14C-glucose into lipids released by the liver.

Authors:  J Letarte; T R Fraser
Journal:  Diabetologia       Date:  1969-10       Impact factor: 10.122

7.  Effect of insulin pretreatment on glucose and lipid metabolism of liver slices from normal rats.

Authors:  L B Salans; G M Reaven
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

8.  Role of insulin in endogenous hypertriglyceridemia.

Authors:  G M Reaven; R L Lerner; M P Stern; J W Farquhar
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

9.  Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man.

Authors:  A H Kissebah; S Alfarsi; P W Adams; V Wynn
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

10.  The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism.

Authors:  D L Topping; P A Mayes
Journal:  Biochem J       Date:  1972-01       Impact factor: 3.857

View more
  10 in total

1.  Impaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoprotein.

Authors:  Ke Wu; David Cappel; Melissa Martinez; John M Stafford
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

2.  Association of FURIN and ZPR1 polymorphisms with metabolic syndrome.

Authors:  Chikara Ueyama; Hideki Horibe; Yuichiro Yamase; Tetsuo Fujimaki; Mitsutoshi Oguri; Kimihiko Kato; Masazumi Arai; Sachiro Watanabe; Toyoaki Murohara; Yoshiji Yamada
Journal:  Biomed Rep       Date:  2015-06-29

3.  Association of a genetic variant of the ZPR1 zinc finger gene with type 2 diabetes mellitus.

Authors:  Fumitaka Tokoro; Reiko Matsuoka; Shintaro Abe; Masazumi Arai; Toshiyuki Noda; Sachiro Watanabe; Hideki Horibe; Tetsuo Fujimaki; Mitsutoshi Oguri; Kimihiko Kato; Shinya Minatoguchi; Yoshiji Yamada
Journal:  Biomed Rep       Date:  2014-11-07

4.  Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance.

Authors:  K P Ratzmann; W Besch; S Witt; B Schulz
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

5.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

Authors:  A Fontbonne; E Eschwège; F Cambien; J L Richard; P Ducimetière; N Thibult; J M Warnet; J R Claude; G E Rosselin
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

6.  Effects of vanadate administration on the high sucrose diet-induced aberrations in normal rats.

Authors:  S Pugazhenthi; J F Angel; R L Khandelwal
Journal:  Mol Cell Biochem       Date:  1993-05-12       Impact factor: 3.396

7.  2-oxocarboxylic acids and function of pancreatic islets in obese-hyperglycaemic mice. Insulin secretion in relation to 45Ca uptake and metabolism.

Authors:  S Lenzen; U Panten
Journal:  Biochem J       Date:  1980-01-15       Impact factor: 3.857

8.  Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia.

Authors:  M Greenfield; O Kolterman; J Olefsky; G M Reaven
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

9.  Evidence for multiple causality in the development of diabetic hypertriglyceridaemia.

Authors:  D Weiland; C E Mondon; G M Reaven
Journal:  Diabetologia       Date:  1980-04       Impact factor: 10.122

10.  Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.

Authors:  Melissa N Barber; Steve Risis; Christine Yang; Peter J Meikle; Margaret Staples; Mark A Febbraio; Clinton R Bruce
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.